1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Antisecretory factor in severe traumatic brain injury (AFISTBI) : protocol for an exploratory randomized placebo-controlled trial
(
- Contribution to journal › Article
- 2024
-
Mark
Comparison of perimetric 24-2 and 30-2 test patterns in detecting visual field defects in patients with tumours in the pituitary region
(
- Contribution to journal › Article
-
Mark
Protumoral lipid droplet-loaded macrophages are enriched in human glioblastoma and can be therapeutically targeted
(
- Contribution to journal › Article
- 2023
-
Mark
Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma
(
- Contribution to journal › Article
-
Mark
Prolonged and intense neuroinflammation after severe traumatic brain injury assessed by cerebral microdialysis with 300 kDa membranes
(
- Contribution to journal › Article
-
Mark
Visual acuity in patients with non-functioning pituitary adenoma : Prognostic factors and long-term outcome after surgery
(
- Contribution to journal › Article
-
Mark
Non-functioning pituitary microadenoma in children and adolescents : Is follow-up with diagnostic imaging necessary?
(
- Contribution to journal › Article
- 2022
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
(
- Contribution to journal › Article
-
Mark
Intratumoral administration of the antisecretory peptide AF16 cures murine gliomas and modulates macrophage functions
(
- Contribution to journal › Article
-
Mark
Novel methods of malignant brain tumor treatment utilizing the tumor microenvironment
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)